로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > Protein > Integrin alpha V beta 8 > IT8-M52W6

Mouse Integrin alpha V beta 8 (ITGAV&ITGB8) Heterodimer Protein, His Tag&Tag Free (MALS verified)

  • Synonym
    Integrin alpha V beta 8,ITGAV&ITGB8
  • Source
    Mouse ITGAV&ITGB8 Heterodimer Protein, His Tag&Tag Free(IT8-M52W6) is expressed from human 293 cells (HEK293). It contains AA Phe 31 - Val 988 (ITGAV) & Gly 22 - Leu 681 (ITGB8) (Accession # P43406-1 (ITGAV) & Q0VBD0-1 (ITGB8)).
    Predicted N-terminus: Phe 31 (ITGAV) & Gly 22 (ITGB8)
  • Molecular Characterization
    Integrin alpha V beta 8 Structure

    Mouse ITGAV&ITGB8 Heterodimer Protein, His Tag&Tag Free, produced by co-expression of ITGAV and ITGB8, has a calculated MW of 112.5 kDa (ITGAV) and 77.5 kDa (ITGB8). Subunit ITGAV is fused with an acidic tail at the C-terminus and followed by a polyhistidine tag and subunit ITGB8 contains no tag but a basic tail at the C-terminus. The non-reducing (NR) protein migrates as 130-150 kDa (ITGAV) and 80-90 kDa (ITGB8) respectively due to glycosylation.

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >95% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 150 mM NaCl, pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
Integrin alpha V beta 8 SDS-PAGE

Mouse ITGAV&ITGB8 Heterodimer Protein, His Tag&Tag Free on SDS-PAGE under non-reducing (NR) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

SEC-MALS
Integrin alpha V beta 8 MALS images

The purity of Mouse ITGAV&ITGB8 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT8-M52W6) is more than 85% and the molecular weight of this protein is around 189-231 kDa verified by SEC-MALS.

Bioactivity-ELISA
 Integrin alpha V beta 8 ELISA

Immobilized Mouse ITGAV&ITGB8 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT8-M52W6) at 5 μg/mL (100 μL/well) can bind Biotinylated Human Latent TGF-Beta 1, His,Avitag (Cat. No. TG1-H82Qb) with a linear range of 1-10 ng/mL (QC tested).

 Integrin alpha V beta 8 ELISA

Immobilized Human Fibronectin at 2 μg/mL (100 μL/well) can bind Mouse ITGAV&ITGB8 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT8-M52W6) with a linear range of 0.156-5 μg/mL (Routinely tested).

 Integrin alpha V beta 8 ELISA

Immobilized Human Vitronectin at 2 μg/mL (100 μL/well) can bind Mouse ITGAV&ITGB8 Heterodimer Protein, His Tag&Tag Free (Cat. No. IT8-M52W6) with a linear range of 0.156-5 μg/mL (Routinely tested).

  • Background
    Integrin alpha V beta 8 (ITGAV & ITGB8 or ITGAVB8) is expressed in yolk sac, placenta, brain perivascular astrocytes, Schwann cells, renal glomerular mesangial cells and pulmonary epithelial cells. Unlike other alpha V integrins, ITGAVB8 does not appear to assume different activation states, and the cytoplasmic tail does not connect to the cytoskeleton. It binds ligands containing an RGD motif, including vitronectin, fibrin and the latency associated peptide (LAP) of the latent TGF-beta complex. High affinity binding of alpha V beta 8 to LAP allows proteolytic cleavage by MT1-MMP, which releases active TGF-beta. This mechanism differs from that of alpha V beta 6, the other alpha V integrin which can activate TGF-beta from latency through non-proteolytic mechanisms. Downstream effects of TGF-beta activation include control of cell growth and associated vascularization.
  • Clinical and Translational Updates

코멘트 (0)


재고상품 출발날짜: 영업일 기준 4일

가격(KRW) : 615,000

가격(KRW) : 4,755,000

보급 및 전시



약물 개발 현황

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:2 Details
  • Latest Research Phase:Phase 2 Clinical

Datasheet & Documentation

DMF 신청
DMF (Drug Master File)

신제품

문의와 컨텐츠

This web search service is supported by Google Inc.

totop